Endodontic Department, Dental Material Research Center, Tehran Dental Branch, Tehran, Iran; Stem Cell Research Center, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Departments of Oral and Maxillofacial Pathology, Tehran University of Medical Sciences, Tehran, Iran.
J Endod. 2018 Nov;44(11):1692-1696. doi: 10.1016/j.joen.2018.07.013. Epub 2018 Sep 18.
A lack of information exists regarding the efficacy of RetroMTA (BioMTA, Seoul, Korea) directly applied on the pulp in vital pulp therapy. This study was designed to examine the clinical efficacy of RetroMTA compared with ProRoot mineral trioxide aggregate (MTA) (Dentsply Tulsa Dental, Tulsa, OK) for partial pulpotomy.
Partial pulpotomy was performed in 22 healthy human maxillary and mandibular third molars planned for extraction. The teeth were randomly divided into 2 groups (n = 11) and underwent partial pulpotomy with RetroMTA and ProRoot MTA as the control. The teeth were then restored with glass ionomer cement. Clinical and electric pulp tests were performed after 1 and 8 weeks. The teeth were radiographed and extracted at 8 weeks. Histologic sections were prepared and analyzed for pulp inflammation and dentinal bridge formation. Data were analyzed using the Mann-Whitney U test.
Clinical examination after 1 and 8 weeks showed no sensitivity to heat, cold, or palpation in the ProRoot MTA and RetroMTA groups. Periapical radiographs taken before the extraction of teeth showed no evidence of periapical pathology. Electric pulp testing revealed no sensitivity. Data comparisons using the Mann-Whitney U test showed no significant difference between the materials with regard to the pulp inflammation type, intensity and extension (P = .3), or bridge continuity (P = .12). However, these data revealed a significant difference between the 2 materials in pulp morphology (P < .05) and bridge thickness (P < .01).
This is the first work to evaluate a RetroMTA histologic outcome in partial pulpotomy in human permanent teeth. It shows pulp disorganization, an absence of inflammation, and discontinuous mineralization, which may represent a potential drawback with RetroMTA in this indication.
直接在活髓治疗的牙髓上应用 RetroMTA(韩国首尔 BioMTA)的疗效信息不足。本研究旨在比较 RetroMTA 与 ProRoot 矿化三氧化物凝聚体(MTA)(Dentsply Tulsa Dental,Tulsa,OK)用于部分活髓切断术的临床疗效。
在计划拔除的 22 颗健康上颌和下颌第三磨牙中进行部分活髓切断术。牙齿随机分为 2 组(n=11),分别用 RetroMTA 和 ProRoot MTA 进行部分活髓切断术作为对照。然后用玻璃离子水门汀修复牙齿。术后 1 周和 8 周进行临床和电牙髓测试。8 周时拍摄 X 线片并拔牙。制备和分析牙髓炎症和牙本质桥形成的组织学切片。数据采用 Mann-Whitney U 检验进行分析。
术后 1 周和 8 周的临床检查显示,ProRoot MTA 和 RetroMTA 组对热、冷或触诊均无敏感性。拔牙前拍摄的根尖片未见根尖病变证据。电牙髓测试显示无敏感性。Mann-Whitney U 检验数据比较显示,2 种材料在牙髓炎症类型、强度和范围(P=.3)或桥连续性(P=.12)方面无显著差异。然而,这些数据显示 2 种材料在牙髓形态(P<.05)和桥厚度(P<.01)方面存在显著差异。
这是首次评估 RetroMTA 在人类恒牙部分活髓切断术中的组织学结果。结果显示牙髓组织紊乱,无炎症,矿化不连续,这可能是 RetroMTA 在该适应证中的一个潜在缺点。